gsc-loaded autologous dendritic cells
Vaccineexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2016 (NCT02820584)
Timeline
Indications
Studied for
Mechanism of action
- Tumor antigensImmunity, active
Tumor antigens immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gsc-loaded autologous dendritic cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04888611 | Phase 2 | Oct 26, 2021 | Fudan University, Hengrui Therapeutics, Inc., Shanghai Sunstem Biotechnology Co., Ltd. |
| NCT02820584 | Phase 1 | Sep 1, 2016 | Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | Academic/Hospital | 1 | 1 | 1 | 2016 |
| Fudan University | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Hengrui Therapeutics, Inc. | For profit | 1 | 0 | 1 | 2021 |
| Shanghai Sunstem Biotechnology Co., Ltd. | For profit | 1 | 0 | 1 | 2021 |
4 organizations
Page 1 / 1